Mutations in the G 13 Pathway Promote GCB-DLBCL Progression

Cancer Discovery - United States
doi 10.1158/2159-8290.cd-rw2014-210
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors

Unknown

Publisher

American Association for Cancer Research (AACR)

Related search

MEF2B Mutations Are Functionally Significant in DLBCL

Cancer Discovery
Oncology
2013English

Prognostic Value of Expression of Nuclear Factor Kappa-B/P65 in Non-GCB DLBCL Patients

Oncotarget
Oncology
2016English

miR-221/222 Promote Malignant Progression of Glioma Through Activation of the Akt Pathway

International Journal of Oncology
Cancer ResearchOncology
2010English

PI3K/AKT/mTOR Pathway Alterations Promote Malignant Progression and Xenograft Formation in Oligodendroglial Tumors

Clinical Cancer Research
Cancer ResearchOncology
2019English

Macrophages Promote Polycystic Kidney Disease Progression

Kidney International
Nephrology
2013English

TP53 Mutations Promote Immunogenic Activity in Breast Cancer

Journal of Oncology
Oncology
2019English

McL1 and DEDD Promote Urothelial Carcinoma Progression

Molecular Cancer Research
Cancer ResearchOncologyMolecular Biology
2019English

CircBANP Acts as a Sponge of Let-7a to Promote Gastric Cancer Progression via the FZD5/Wnt/β-catenin Pathway

RSC Advances
ChemistryChemical Engineering
2020English

Interaction of G 12 With G 13 and G Q Signaling Pathways

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2002English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy